BlueStar, developed by healthcare technology firm WellDoc, provides real-time recommendations to diabetes patients on glucose monitoring, and sends a patient’s glucose levels and other data directly to his or her physician, according to the report.
The app required FDA approval because it makes medical suggestions to physicians, according to the report.
More Articles on mHealth:
Aetna’s New App to Allow Patients to Monitor Own Health Data
Poll: One-Third of Americans Want to Use Mobile Devices for Physician Communication
Report: 19 Percent of Smartphone Users Have Health App
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.